{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihjdmhdgj4dlwlpstukm3wtue7hwwzqkperqxpw55w7a4gf455zmu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mher4nwl5xp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihd5rhhh776pievxqgtmcgbkhv7d742adctmd4vtfx6kzaaaxegua"
    },
    "mimeType": "image/jpeg",
    "size": 137590
  },
  "path": "/news/2026-03-glp-medications-diabetes-obesity-alleviate.html",
  "publishedAt": "2026-03-18T19:30:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out in collaboration between the University of Eastern Finland, Karolinska Institutet in Stockholm and Griffith University in Australia.",
  "title": "GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression"
}